Galapagos NV is a global biotechnology company (Euronext & Nasdaq: GLPG) with operations in Europe, the United States and Asia. The company is dedicated to transforming patient outcomes through life-changing science and innovation. Galapagos is currently entering a new phase in its strategic transfo